Pursuit of an rmat designation for an unexpected patient population
Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5, SupplementAuthor(s): S.P. Westover (Source: Cytotherapy)
Source: Cytotherapy - May 12, 2021 Category: Cytology Source Type: research
Systematic review of economic evaluations of advanced therapy medical products
Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5, SupplementAuthor(s): A. Olry-De-Labry-Lima, Ä. Ponce-Polo, M. Ortega Ortega, L. Garcia Mochon, R. Oruezabal, D.M. Epstein (Source: Cytotherapy)
Source: Cytotherapy - May 12, 2021 Category: Cytology Source Type: research
Host immune status influence the pre-clinical v al idity of results from in vivo investigation of cellular therapies
Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5, SupplementAuthor(s): W. Vaughan, J. Bolander, K. Desai, A. Moviglia (Source: Cytotherapy)
Source: Cytotherapy - May 12, 2021 Category: Cytology Source Type: research
Standard regulation for stem cell products in indonesia
Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5, SupplementAuthor(s): A. Chouw, G. Facicilia, A.N. Arofah, M.N. Kirana, Y. Dirgantara, S.F. Jundan, Z. Alifah, C.R. Sartika, S. Mutia (Source: Cytotherapy)
Source: Cytotherapy - May 12, 2021 Category: Cytology Source Type: research
Key aspects to consider for the development of a regulatory framework for the use of cell therapies
Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5, SupplementAuthor(s): A.A. Caicedo, S. Sanon, K. Zambrano, S. Canizares, M. Balcazar (Source: Cytotherapy)
Source: Cytotherapy - May 12, 2021 Category: Cytology Source Type: research
A compendial automated and rapid sterility testing technology for cell and gene therapy products through regulatory perspective and industrial application
Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5, SupplementAuthor(s): A. Paris (Source: Cytotherapy)
Source: Cytotherapy - May 12, 2021 Category: Cytology Source Type: research
How institutional biosafety committees contribute to safety, capacity and regulatory approvals in cell and gene therapy trials
Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5, SupplementAuthor(s): G. O’Sullivan, B. Yu, C. Bailey, Z. Velickovic, J. Rasko (Source: Cytotherapy)
Source: Cytotherapy - May 12, 2021 Category: Cytology Source Type: research
The position of the u.s. pharmcopeia on risk-based microbial testing of cell therapies
Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5, SupplementAuthor(s): T. Cundell (Source: Cytotherapy)
Source: Cytotherapy - May 12, 2021 Category: Cytology Source Type: research
The stemcellfactory: automated generation and expansion of human induced pluripotent stem cells
Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5, SupplementAuthor(s): B. Nießing, Y. Breitkreuz, A. Elanzew, N. Koenig, R. Schmitt, O. Brüstle (Source: Cytotherapy)
Source: Cytotherapy - May 12, 2021 Category: Cytology Source Type: research
The new legal framework for minimally manipulated cells expands the possibilities for cell therapy in Russia
Publication date: Available online 10 May 2021Source: CytotherapyAuthor(s): Olga A. Krasilnikova, Ilya D. Klabukov, Denis S. Baranovskii, Peter V. Shegay, Andrey D. Kaprin (Source: Cytotherapy)
Source: Cytotherapy - May 11, 2021 Category: Cytology Source Type: research
Infusion reactions in natural killer cell immunotherapy: a retrospective review
Publication date: Available online 9 May 2021Source: CytotherapyAuthor(s): Tewodros Mamo, Shelly M. Williams, Stephanie Kinney, Katelyn M. Tessier, Todd E. DeFor, Sarah Cooley, Jeffrey S. Miller, David H. McKenna (Source: Cytotherapy)
Source: Cytotherapy - May 10, 2021 Category: Cytology Source Type: research
Blockade of transforming growth factor β2 by anti-sense oligonucleotide improves immunotherapeutic potential of IL-2 against melanoma in a humanized mouse model
Publication date: Available online 9 May 2021Source: CytotherapyAuthor(s): Hong Kyu Lee, Hye-Ji Shin, Jihye Koo, Tae Hun Kim, Cho-Won Kim, Ryeo-Eun Go, Yeon Hee Seong, Jun-Eui Park, Kyung-Chul Choi (Source: Cytotherapy)
Source: Cytotherapy - May 9, 2021 Category: Cytology Source Type: research
A novel non-viral delivery method that enables efficient engineering of primary human T cells for ex vivo cell therapy applications
Publication date: Available online 1 May 2021Source: CytotherapyAuthor(s): Heather Kavanagh, Susan Dunne, Darren S. Martin, Emily McFadden, Louise Gallagher, Jessica Schwaber, Siobhán Leonard, Shirley O'Dea (Source: Cytotherapy)
Source: Cytotherapy - May 1, 2021 Category: Cytology Source Type: research
Mesenchymal Stromal Cell therapy for COVID-19: Which? When? And How Much?
Publication date: Available online 30 April 2021Source: CytotherapyAuthor(s): Pradnya Shahani, Indrani Datta (Source: Cytotherapy)
Source: Cytotherapy - April 30, 2021 Category: Cytology Source Type: research
Aims and Scope
Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5Author(s): (Source: Cytotherapy)
Source: Cytotherapy - April 30, 2021 Category: Cytology Source Type: research
